Literature DB >> 2719912

Thiorphan and retro-thiorphan display equivalent interactions when bound to crystalline thermolysin.

S L Roderick1, M C Fournie-Zaluski, B P Roques, B W Matthews.   

Abstract

The three-dimensional structures of (S)-thiorphan and (R)-retro-thiorphan bound to thermolysin have been determined crystallographically and refined to residuals of 0.183 and 0.187 at 1.7-A resolution. Thiorphan [N-[(S)-2-(mercaptomethyl)-1-oxo-3-phenylpropyl]glycine] [HSCH2CH(CH2C6H5)CONHC-H2COOH] and retro-thiorphan [[[(R)-1-(mercaptomethyl)-2-phenylethyl] amino]-3-oxopropanoic acid] [HSCH2CH(CH2C6H5)NHCOCH2COOH] are isomeric thiol-containing inhibitors of endopeptidase EC 24-11 (also called "enkephalinase"). The mode of binding of thiorphan to thermolysin is similar to that of (2-benzyl-3-mercaptopropanoyl)-L-alanylglycinamide [Monzingo, A.F., & Matthews, B.W. (1982) Biochemistry 21, 3390-3394] with the inhibitor sulfur atom coordinated to the active site zinc and the peptide portion forming substrate-like interactions with the enzyme. The isomeric inhibitor retro-thiorphan, which differs from thiorphan by the inversion of an amide bond, utilizes very similar interactions with enzyme. Despite the inversion of the -CO-NH- linkage the carbonyl oxygen and amide nitrogen display very similar hydrogen bonding, as anticipated by B.P. Roques et al. [(1983) Proc. Natl. Acad. Sci. U.S.A. 80, 3178-3182]. These results explain why thermolysin and possibly other zinc endopeptidases such as endopeptidase EC 24-11 fail to discriminate between these retro-inverso inhibitors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2719912     DOI: 10.1021/bi00430a011

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  A tyrosine residue essential for catalytic activity in aminopeptidase A.

Authors:  G Vazeux; X Iturrioz; P Corvol; C Llorens-Cortès
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

Review 2.  Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1998-07       Impact factor: 3.686

3.  QXP: powerful, rapid computer algorithms for structure-based drug design.

Authors:  C McMartin; R S Bohacek
Journal:  J Comput Aided Mol Des       Date:  1997-07       Impact factor: 3.686

4.  Flexible matching of test ligands to a 3D pharmacophore using a molecular superposition force field: comparison of predicted and experimental conformations of inhibitors of three enzymes.

Authors:  C McMartin; R S Bohacek
Journal:  J Comput Aided Mol Des       Date:  1995-06       Impact factor: 3.686

5.  The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1994-06       Impact factor: 3.686

6.  A Transferable Non-bonded Pairwise Force Field to Model Zinc Interactions in Metalloproteins.

Authors:  Ruibo Wu; Zhenyu Lu; Zexing Cao; Yingkai Zhang
Journal:  J Chem Theory Comput       Date:  2011-02-08       Impact factor: 6.006

7.  Cloning and characterization of Aplysia neutral endopeptidase, a metallo-endopeptidase involved in the extracellular metabolism of neuropeptides in Aplysia californica.

Authors:  J P Zappulla; L Wickham; W Bawab; X F Yang; M V Storozhuk; V F Castellucci; L DesGroseillers
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

8.  The structure of Mlc titration factor A (MtfA/YeeI) reveals a prototypical zinc metallopeptidase related to anthrax lethal factor.

Authors:  Qingping Xu; Anna-Katharina Göhler; Anne Kosfeld; Dennis Carlton; Hsiu-Ju Chiu; Heath E Klock; Mark W Knuth; Mitchell D Miller; Marc-André Elsliger; Ashley M Deacon; Adam Godzik; Scott A Lesley; Knut Jahreis; Ian A Wilson
Journal:  J Bacteriol       Date:  2012-03-30       Impact factor: 3.490

9.  Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension.

Authors:  M C Fournié-Zaluski; W Gonzalez; S Turcaud; I Pham; B P Roques; J B Michel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  Stimulation and oxidative catalytic inactivation of thermolysin by copper.Cys-Gly-His-Lys.

Authors:  Nikhil H Gokhale; Seth Bradford; J A Cowan
Journal:  J Biol Inorg Chem       Date:  2007-07-06       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.